Management of Unconjugated Hyperbilirubinemia

Phototherapy Guidelines

The American Academy of Pediatrics recommends phototherapy as the primary treatment for unconjugated hyperbilirubinemia in neonates ≥35 weeks gestation, using blue-green LED lights (460-490 nm) at irradiance ≥30 μW·cm⁻²·nm⁻¹, which safely decreases total serum bilirubin within 4-6 hours when properly administered 1, 2, 3
Phototherapy should be initiated at lower total serum bilirubin (TSB) levels in younger infants, as the primary goal is preventing additional TSB increases 9, 5
The American Academy of Pediatrics suggests that TSB should decrease within the first 4-6 hours of effective phototherapy initiation 1, 2

Initial laboratory evaluation should include measurement of total serum bilirubin (TSB) and direct/conjugated bilirubin immediately for any jaundice in the first 24 hours of life, as well as blood type, Rh status, and direct antibody test (Coombs) 3, 4
Infants with significant hyperbilirubinemia should be tested for G6PD deficiency, as these infants require intervention at lower TSB thresholds and may develop sudden bilirubin increases 5, 4

The American Academy of Pediatrics recommends initiation of phototherapy based on TSB threshold values, which are determined by gestational age, postnatal age, and presence of risk factors for bilirubin neurotoxicity 1, 2
Treatment thresholds are lower for infants 35-36 weeks gestation due to increased risk of bilirubin neurotoxicity 4
TSB should be measured within 4-24 hours after initiating phototherapy, depending on initial level and rate of rise, and plotted on hour-specific nomograms to track response 7, 4

The American Academy of Pediatrics suggests that intravenous immunoglobulin (IVIG) be administered to infants with isoimmune hemolytic disease (ABO or Rh incompatibility) and rising TSB despite intensive phototherapy, at a dose of 0.5-1 g/kg intravenously over 2-4 hours 3, 7
Exchange transfusion is reserved for extreme hyperbilirubinemia unresponsive to intensive phototherapy and should only be performed by trained personnel in a neonatal intensive care unit with full monitoring and resuscitation capabilities 3, 10, 9, 5

Eye masks should be applied to prevent theoretical retinal damage during phototherapy, although human evidence is lacking 8, 7
Feeding should be continued every 2-3 hours to maintain adequate hydration, and IV fluids should be provided if dehydration is present or oral intake is inadequate 3, 7
Phototherapy does not exacerbate hemolysis, but contraindications include congenital porphyria and photosensitizing drug exposure 8, 7
Critical errors to avoid include relying on visual estimation of jaundice, interrupting phototherapy until documented bilirubin decrease occurs, and missing G6PD deficiency 4, 7, 9, 5